Real-World Evidence & Market Access Symposium

Real-world evidence is an essential springboard to improved patient access and commercial success. By selecting the right databases, you can vastly deepen your understanding of disease epidemiology and the patient journey.

DGE’s Real-World Evidence & Market Access Summit gives you the practical knowledge you need to clearly gauge the effectiveness of treatment options and the value your products offer in each patient subgroup. No other life science conference focuses specifically on this topic while streaming on a proven interactive online platform!

Agenda at a Glance

Topics covered will include:

Unprecedented Impact of RWE During COVID 19 Pandemic and What to Expect in the Future
Gain Regulatory Insight on FDA Initiatives to Optimize RWE
Determine What Evidence is Needed to Justify Use of RWE for Approval of New Indications or Expand Labeling
Evaluate the Potential for Using RWE as a Synthetic Control Arm
Gain Insight on Using RWE to Demonstrate Value, Support Coverage Decisions and Pricing

Top Reasons to Attend

Benchmark Strategies for Meeting Regulatory and Payer Needs for Real World Evidence
Approaches for Providing HEOR Insights Across the Product Lifecycle
Toolkit for Identifying Unmet Patient Needs in Rare Disease
A Map for Applying Real World Evidence to Communications Strategies to Achieve Launch Excellence
Plans for Using AI and Machine Learning to Extract and Analyze Data